Cargando…

Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is an independent risk factor for lung cancer development, and small cell lung cancer (SCLC) comprises 15-20% of lung cancers with IPF. The objective of this study was to investigate survival outcomes and treatment-related complications according to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Myung Jin, Lim, Sung Yoon, Park, Jong Sun, Yoon, Ho il, Lee, Jae-Ho, Kim, Song Yee, Jung, Ji Ye, Kang, Young Ae, Park, Moo Suk, Kim, Young Sam, Chang, Joon, Lee, Sang Hoon, Lee, Choon-Taek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521435/ https://www.ncbi.nlm.nih.gov/pubmed/31186636 http://dx.doi.org/10.1155/2019/5437390

Ejemplares similares

Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study
por: Song, Myung Jin, et al.
Publicado: (2021)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
por: Moon, Sung Woo, et al.
Publicado: (2019)

The relationship between the severity of pulmonary fibrosis and the lung cancer stage
por: Jang, Hye Jin, et al.
Publicado: (2021)

Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study
por: Lee, Sang Hoon, et al.
Publicado: (2018)

Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
por: Lee, Sang Hoon, et al.
Publicado: (2016)

Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis
por: Lee, Ye Jin, et al.
Publicado: (2017)

Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital
por: Song, Myung Jin, et al.
Publicado: (2020)

Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study
por: Lee, Sang Hoon, et al.
Publicado: (2016)

Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
por: Han, SongYi, et al.
Publicado: (2019)

Efficacy of lower dose pirfenidone for idiopathic pulmonary fibrosis in real practice: a retrospective cohort study
por: Hwang, Hyeontaek, et al.
Publicado: (2022)

Prognostic impact of the ratio of the main pulmonary artery to that of the aorta on chest computed tomography in patients with idiopathic pulmonary fibrosis
por: Choi, Ji Soo, et al.
Publicado: (2019)

Mycobacterial Pulmonary Infections in Patients with Idiopathic Pulmonary Fibrosis
por: Park, Sung-Woo, et al.
Publicado: (2012)

Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients
por: Moon, Sung Woo, et al.
Publicado: (2019)

Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
por: Sin, Sooim, et al.
Publicado: (2018)

Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone
por: Kim, Tae Hun, et al.
Publicado: (2022)

Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
por: Lee, Eun Hye, et al.
Publicado: (2017)

Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age
por: Bae, Won, et al.
Publicado: (2016)

A nationwide population-based study of incidence and mortality of lung cancer in idiopathic pulmonary fibrosis
por: Song, Myung Jin, et al.
Publicado: (2021)

Prognosis of nontuberculous mycobacterial pulmonary disease according to the method of microbiologic diagnosis
por: Sin, Sooim, et al.
Publicado: (2021)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
por: Lee, Sang Hoon, et al.
Publicado: (2019)

Clinical Characteristics of Idiopathic Pulmonary Fibrosis Patients with Diabetes Mellitus: the National Survey in Korea from 2003 to 2007
por: Kim, Yu Jin, et al.
Publicado: (2012)

Histologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
por: Kim, Ho Cheol, et al.
Publicado: (2020)

Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
por: Chung, Man Pyo, et al.
Publicado: (2020)

Impact of non-cystic fibrosis bronchiectasis on critically ill patients in Korea: a retrospective observational study
por: Park, Youngmok, et al.
Publicado: (2021)

Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia
por: Kang, Young Ae, et al.
Publicado: (2009)

Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis
por: Park, Youngmok, et al.
Publicado: (2018)

Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease
por: Chung, Eunki, et al.
Publicado: (2023)

Impact of Toxocariasis in Patients with Unexplained Patchy Pulmonary Infiltrate in Korea
por: Yoon, Young-Soon, et al.
Publicado: (2009)

Drug-induced Hepatotoxicity of Anti-tuberculosis Drugs and Their Serum Levels
por: Jeong, Ina, et al.
Publicado: (2015)

Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007–2010
por: Moon, Sung Woo, et al.
Publicado: (2018)

Utility and safety of sole electromagnetic navigation bronchoscopy under moderate sedation for lung cancer diagnosis
por: Kim, Yeon Wook, et al.
Publicado: (2022)

Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
por: Lee, Jong-Uk, et al.
Publicado: (2017)

Predictors and outcomes of sepsis-induced cardiomyopathy in critically ill patients
por: Song, Myung Jin, et al.
Publicado: (2020)

Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study
por: Lee, Ho Young, et al.
Publicado: (2023)

CT quantification of the heterogeneity of fibrosis boundaries in idiopathic pulmonary fibrosis
por: Park, Junghoan, et al.
Publicado: (2021)

Tuberculin Skin Test and Boosted Reactions among Newly Employed Healthcare Workers: An Observational Study
por: Kim, Song Yee, et al.
Publicado: (2013)

Readmission to Medical Intensive Care Units: Risk Factors and Prediction
por: Jo, Yong Suk, et al.
Publicado: (2015)

Gene profile of fibroblasts identify relation of CCL8 with idiopathic pulmonary fibrosis
por: Lee, Jong-Uk, et al.
Publicado: (2017)

The significance of elevated tumor markers among patients with interstitial lung diseases
por: Kwon, Byoung Soo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7lorcc6bme57pvdoc6v0o03tvn